Guiheen Lawrence P. 4

4 · ADMA BIOLOGICS, INC. · Filed Feb 11, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

ADMA Director Lawrence Guiheen Receives RSU Award

What Happened

Lawrence P. Guiheen, a director of ADMA BIOLOGICS, reported awards on Feb 9, 2026: a grant of 10,690 restricted stock units (RSUs) and a derivative award of 17,730 units (total 28,420 units) at $0.00 (compensation awards, not purchases). No cash was paid; these are equity compensation awards that convert to shares only if and when they vest.

Key Details

Transaction date: 2026-02-09; filing date (Form 4): 2026-02-11 (filed within the standard 2-business-day window).
Price: $0.00 per unit (award/grant, transaction code A).
Vesting: The newly granted RSUs vest in two equal installments (six- and 12-month anniversaries) and become fully vested on the one-year anniversary, subject to continued service (see footnote F1). Footnote F2 notes the 10,690 RSUs will fully vest on 2027-02-09 and also references 5,445 RSUs from a 2025 grant that vest 2026-02-19.
Shares/units reported after transaction: the filing references ownership of 89,385 shares of common stock (which includes 50,990 shares held in an irrevocable trust per F3) plus outstanding RSUs noted above.
Transaction type: Award/Grant (A). These are not open-market buys or sales.

Context

RSUs and derivative awards are compensation and do not represent immediately tradable shares; they convert to common stock only upon vesting. This filing reflects routine director compensation rather than a market purchase or sale.

Form 4

Period: 2026-02-09

Director

Transactions

Award
Common Stock
[F1][F2]
2026-02-09+10,690→ 105,520 total
Award
Stock Option (Right to Buy)
[F4]
2026-02-09+17,730→ 17,730 total
Exercise: $16.37Exp: 2036-02-09→ Common Stock (17,730 underlying)

Holdings

Footnotes (4)

[F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
[F2]Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 89,385 shares of common stock owned by the Reporting Person.
[F3]Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1.
[F4]These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Signature

/s/ Lawrence P. Guiheen, by Michael A. Goldstein as Attorney-in-fact|2026-02-11

1 file